# Lamzede

NDC: 10122-180
Generic name: Velmanase alfa-tycv
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230301

FDA application: BLA761278

## Active ingredients

- VELMANASE ALFA-TYCV: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-180"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-180
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36d50a08-60bd-40eb-807c-778d69bf2d2e